SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950103-21-004764
Filing Date
2021-03-29
Accepted
2021-03-29 17:18:29
Documents
14
Period of Report
2021-03-29
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp148583_8k.htm   iXBRL 8-K 46191
2 EXHIBIT 99.1 dp148583_ex9901.htm EX-99.1 11017
6 GRAPHIC image_001.jpg GRAPHIC 3655
  Complete submission text file 0000950103-21-004764.txt   243659

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE crl-20210329.xsd EX-101.SCH 3169
4 XBRL LABEL FILE crl-20210329_lab.xml EX-101.LAB 34592
5 XBRL PRESENTATION FILE crl-20210329_pre.xml EX-101.PRE 22700
7 EXTRACTED XBRL INSTANCE DOCUMENT dp148583_8k_htm.xml XML 3506
Mailing Address 251 BALLARDVALE ST WILMINGTON MA 01887
Business Address 251 BALLARDVALE ST WILMINGTON MA 01887 781-222-6000
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (Filer) CIK: 0001100682 (see all company filings)

IRS No.: 061397316 | Fiscal Year End: 1226
Type: 8-K | Act: 34 | File No.: 001-15943 | Film No.: 21782629
SIC: 8731 Services-Commercial Physical & Biological Research